Deutsche Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $323M | Sell |
518,409
-106,979
| -17% | -$72.8M | 0.09% | 201 |
|
|
2026
Q1 | $483M | Sell |
625,388
-138,538
| -18% | -$106M | 0.16% | 137 |
|
|
2025
Q4 | $590M | Buy |
763,926
+67,245
| +10% | +$45.7M | 0.19% | 112 |
|
|
2025
Q3 | $392M | Sell |
696,681
-14,156
| -2% | -$8M | 0.13% | 158 |
|
|
2025
Q2 | $373M | Buy |
710,837
+167,745
| +31% | +$93.6M | 0.14% | 154 |
|
|
2025
Q1 | $344M | Buy |
543,092
+3,823
| +0.7% | +$2.63M | 0.14% | 152 |
|
|
2024
Q4 | $384M | Buy |
539,269
+96,329
| +22% | +$80.8M | 0.15% | 138 |
|
|
2024
Q3 | $466M | Buy |
442,940
+41,768
| +10% | +$46.5M | 0.19% | 104 |
|
|
2024
Q2 | $422M | Buy |
401,172
+89,096
| +29% | +$86.4M | 0.19% | 109 |
|
|
2024
Q1 | $300M | Sell |
312,076
-13,319
| -4% | -$12.7M | 0.14% | 145 |
|
|
2023
Q4 | $286M | Buy |
325,395
+53,764
| +20% | +$44.3M | 0.15% | 144 |
|
|
2023
Q3 | $224M | Sell |
271,631
-28,150
| -9% | -$22.1M | 0.14% | 146 |
|
|
2023
Q2 | $215M | Sell |
299,781
-2,971
| -1% | -$2.29M | 0.11% | 171 |
|
|
2023
Q1 | $249M | Sell |
302,752
-21,286
| -7% | -$16.1M | 0.14% | 157 |
|
|
2022
Q4 | $234M | Sell |
324,038
-1,216
| -0.4% | -$897K | 0.13% | 160 |
|
|
2022
Q3 | $224M | Sell |
325,254
-37,570
| -10% | -$23.6M | 0.14% | 153 |
|
|
2022
Q2 | $214M | Sell |
362,824
-49,181
| -12% | -$32M | 0.12% | 165 |
|
|
2022
Q1 | $288M | Sell |
412,005
-2,936
| -0.7% | -$1.86M | 0.13% | 155 |
|
|
2021
Q4 | $262M | Sell |
414,941
-34,017
| -8% | -$20.9M | 0.12% | 169 |
|
|
2021
Q3 | $272M | Sell |
448,958
-52,753
| -11% | -$32.7M | 0.13% | 160 |
|
|
2021
Q2 | $280M | Buy |
501,711
+37,449
| +8% | +$19M | 0.14% | 157 |
|
|
2021
Q1 | $220M | Buy |
464,262
+34,491
| +8% | +$16.8M | 0.12% | 174 |
|
|
2020
Q4 | $208M | Buy |
429,771
+52,914
| +14% | +$28.6M | 0.13% | 162 |
|
|
2020
Q3 | $211M | Buy |
376,857
+15,336
| +4% | +$9.3M | 0.15% | 136 |
|
|
2020
Q2 | $225M | Sell |
361,521
-29,797
| -8% | -$16.9M | 0.17% | 118 |
|
|
2020
Q1 | $191M | Sell |
391,318
-82,329
| -17% | -$34M | 0.17% | 118 |
|
|
2019
Q4 | $178M | Sell |
473,647
-155,540
| -25% | -$52.3M | 0.12% | 179 |
|
|
2019
Q3 | $175M | Buy |
629,187
+33,249
| +6% | +$9.84M | 0.12% | 172 |
|
|
2019
Q2 | $187M | Buy |
595,938
+82,934
| +16% | +$27.6M | 0.11% | 193 |
|
|
2019
Q1 | $211M | Buy |
513,004
+22,918
| +5% | +$9.44M | 0.13% | 168 |
|
|
2018
Q4 | $183M | Buy |
490,086
+6,798
| +1% | +$2.49M | 0.13% | 167 |
|
|
2018
Q3 | $195M | Sell |
483,288
-308,666
| -39% | -$117M | 0.1% | 220 |
|
|
2018
Q2 | $273M | Sell |
791,954
-357,012
| -31% | -$112M | 0.14% | 157 |
|
|
2018
Q1 | $396M | Buy |
1,148,966
+611,885
| +114% | +$213M | 0.19% | 107 |
|
|
2017
Q4 | $202M | Buy |
537,081
+272,122
| +103% | +$110M | 0.13% | 158 |
|
|
2017
Q3 | $118M | Buy |
264,959
+46,994
| +22% | +$22.4M | 0.08% | 286 |
|
|
2017
Q2 | $107M | Sell |
217,965
-39,558
| -15% | -$17.3M | 0.08% | 296 |
|
|
2017
Q1 | $99.8M | Buy |
257,523
+45,536
| +21% | +$16.9M | 0.07% | 302 |
|
|
2016
Q4 | $77.8M | Sell |
211,987
-61,354
| -22% | -$23.3M | 0.06% | 348 |
|
|
2016
Q3 | $110M | Sell |
273,341
-18,371
| -6% | -$7.37M | 0.08% | 293 |
|
|
2016
Q2 | $102M | Buy |
291,712
+20,223
| +7% | +$7.79M | 0.07% | 317 |
|
|
2016
Q1 | $97.9M | Buy |
271,489
+2,015
| +0.7% | +$830K | 0.07% | 302 |
|
|
2015
Q4 | $146M | Sell |
269,474
-104,699
| -28% | -$56.7M | 0.1% | 234 |
|
|
2015
Q3 | $174M | Sell |
374,173
-122,531
| -25% | -$65.8M | 0.13% | 175 |
|
|
2015
Q2 | $253M | Sell |
496,704
-141,560
| -22% | -$69.1M | 0.16% | 156 |
|
|
2015
Q1 | $288M | Sell |
638,264
-48,411
| -7% | -$20.5M | 0.18% | 131 |
|
|
2014
Q4 | $282M | Sell |
686,675
-31,895
| -4% | -$12.5M | 0.17% | 129 |
|
|
2014
Q3 | $259M | Sell |
718,570
-21,508
| -3% | -$7.21M | 0.16% | 147 |
|
|
2014
Q2 | $209M | Sell |
740,078
-104,757
| -12% | -$31M | 0.14% | 167 |
|
|
2014
Q1 | $254M | Sell |
844,835
-87,551
| -9% | -$27M | 0.18% | 127 |
|
|
2013
Q4 | $257M | Sell |
932,386
-172,563
| -16% | -$49.6M | 0.18% | 115 |
|
|
2013
Q3 | $346M | Buy |
1,104,949
+691,649
| +167% | +$182M | 0.26% | 72 |
|
|
2013
Q2 | $92.9M | Buy |
+413,300
| New | +$96.2M | 0.08% | 293 |
|
Other funds holding REGN
Deutsche Bank's REGN Position: Q2 2026 in Review
Deutsche Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 17% in Q2 2026, selling an estimated $72.8M and leaving 518,409 shares worth $323M. The position accounts for 0.09% of the portfolio, ranked #201.
Deutsche Bank first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $590M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Deutsche Bank held 518,409 shares of Regeneron Pharmaceuticals worth $323M as of Q2 2026.
- Deutsche Bank sold 106,979 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $72.8M.
- Regeneron Pharmaceuticals made up 0.09% of Deutsche Bank's portfolio in Q2 2026, its #201 holding.
- Deutsche Bank first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Deutsche Bank's Regeneron Pharmaceuticals position peaked at $590M in Q4 2025.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.